课题基金 / 基金详情

项目摘要

项目成果

KELLI LEA PALMER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Enterococci are opportunistic pathogens that cause life-threatening infections in humans. An overarching goal of my research is to characterize mechanisms contributing to the evolution of antibiotic resistance in the enterococci. The proposed research will focus on Enterococcus faecalis, which since the 1980s has gained increasing notoriety from association with hospital-acquired infections and multidrug resistance including resistance to the last-line antibiotic vancomycin. Certain phylogenetic lineages of E. faecalis are associated with antibiotic resistance acquired through horizontal gene transfer and hospital endemicity - these are the high-risk, or hospital-adapted, lineages. The proposed research concerns the relationship of the recently discovered putative prokaryotic immune system, Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas, with the emergence and continuing persistence of multidrug resistant E. faecalis. Loss of CRISPR-Cas defense may have contributed to the evolution and expansion of high-risk enterococcal lineages by enabling acquisition of new traits, such as antibiotic resistance, that facilitate persistence i clinical environments. The specific aims of this research are to: 1) test the hypothesis that CRISPR-Cas interferes with plasmid acquisition by E. faecalis, 2) characterize requirements for small CRISPR RNA processing, and 3) analyze E. faecalis population structure by CRISPR typing. This research will provide insight into a potential mechanism contributing to antibiotic resistance and virulence gene accretion in E. faecalis, and has implications for the identification of E. faecalis strains safe for industrial use. The bacterium Enterococcus faecalis is among the leading causes of healthcare-associated infections in the United States. Multidrug resistance acquired by horizontal gene transfer is characteristic of high-risk E. faecalis strains. The proposed research will evaluate the role of the putative prokaryotic immune system CRISPR-Cas in control of horizontal gene transfer in E. faecalis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genome defense and acquired antibiotic resistance in Enterococcus faecalis and Enterococcus faecium
  • 批准号:
    8981386
  • 项目类别:
  • 资助金额:
    $38.25万
  • 财政年份:
    2015
  • 负责人:
    KELLI LEA PALMER
  • 依托单位:
Genome defense and acquired antibiotic resistance in Enterococcus faecalis and Enterococcus faecium
  • 批准号:
    9248244
  • 项目类别:
  • 资助金额:
    $38.25万
  • 财政年份:
    2015
  • 负责人:
    KELLI LEA PALMER
  • 依托单位:
Genome defense and acquired antibiotic resistance in Enterococcus faecalis and Enterococcus faecium
  • 批准号:
    9054777
  • 项目类别:
  • 资助金额:
    $38.25万
  • 财政年份:
    2015
  • 负责人:
    KELLI LEA PALMER
  • 依托单位:
Novel Strategy for Endophthalmitis Drug Targets
海外基金